Research
This week’s research roundup features a study on how abnormal expression of programmed death-1 (PD-1) ligand-1(PD-L1) in cancer cells play a crucial role in cancer immune evasion and progression.
This week’s research roundup features a study the identification of a novel homozygous multi-exon duplication in RYR2 among children with exertion-related unexplained sudden deaths in the Amish community.
Traditionally, Mayo Clinic's Simulation Center is used for surgical procedures and teaching students how to run a code. Mayo Clinic pathology consultant Karen Fritchie, M.D., recently developed a new and innovative way to use the center.
This week's research roundup features a study on RINT1 bi-allelic variations that cause infantile-onset recurrent acute liver failure and skeletal abnormalities.
This week's research roundup features a study on late relapses in patient with diffuse large b-cell lymphoma who were treated with immunochemotherapy.
This week's research roundup features research on the phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human pappillomavirus-associated oropharynx squamous cell carcinoma.
This week's research roundup features a study on the joint association of mammographic density and polygenic risk score and how they contribute to the prediction of breast cancer.
Mayo Clinic's Center for Individualized Medicine (CIM) is nearing the finish line of the first stage of its unique RIGHT 10K study—an effort that doesn't involve running shoes but nevertheless is paving the way to prescribing medications matched to a person’s genetic code.
Just as money in the bank boosts your financial well-being, biobanks have the power to impact your health. Think of biobank samples as assets that researchers can draw upon to improve disease treatments.
Melanoma, the skin cancer often associated with sun exposure, is on the rise and has no reliable cure. Mayo Clinic is at the forefront of these efforts. The Center for Individualized Medicine is unraveling the complex behavior of melanoma at the molecular level—to allow for treatment that better targets an individual's disease.